CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor Forum

Rhea-AI Summary

CooperCompanies (NYSE: COO) will participate in the KeyBanc Life Sciences MedTech Investor Forum on March 24, 2021. Brian Andrews, the Executive Vice President and CFO, will represent the company in a virtual session starting at 1:15 PM ET. A live webcast will be accessible on Cooper's Investor Relations website, with an archived audio file available later that day. CooperCompanies is a global leader in medical devices, operating through CooperVision and CooperSurgical, and is headquartered in San Ramon, CA.

News Market Reaction – COO

-1.76%

-1.76% Session move

In the trading session that priced this news, COO declined 1.76%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAMON, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:15PM ET.

A live webcast of the Company’s session will be available on the Investor Relations section of CooperCompanies’ website at http://investor.coopercos.com. An archived audio file will be available for replay on the same webpage later in the day.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:

Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com

 

FAQ

When is CooperCompanies participating in the KeyBanc Life Sciences MedTech Investor Forum?

CooperCompanies will participate in the KeyBanc Life Sciences MedTech Investor Forum on March 24, 2021.

Who will represent CooperCompanies at the investor forum?

Brian Andrews, Executive Vice President and CFO, will represent CooperCompanies at the investor forum.

What time is CooperCompanies' session at the forum?

CooperCompanies' session at the forum is scheduled to begin at 1:15 PM ET.

Where can I watch the CooperCompanies investor forum session?

You can watch the CooperCompanies investor forum session live on their Investor Relations website.

Will there be a replay available for CooperCompanies' forum session?

Yes, an archived audio file of CooperCompanies' forum session will be available for replay later in the day.